Table 1.

Correlation between the babA2 andcagA genotypes and disease prevalence

Clinical outcomeNo. (%) of positive strains
babA2cagA
Gastric ulcer (n = 45)38 (84.4)43 (95.6)
Duodenal ulcer (n = 41)35 (85.4)39 (95.1)
Nonulcer dyspepsia (n = 42)34 (81.0)41 (97.6)
Gastric adenocarcinoma (n = 40)36 (90.0)40 (100)
MALT lymphoma (n = 11)9 (81.8)9 (81.8)
Total (n = 179)152 (84.9)172 (96.1)